Terms: = Head and neck cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Staging
2826 results:
1. Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
Wang Y; Wu Y; Zheng C; Li Q; Jiao W; Wang J; Xiao L; Pang Q; Zhang W; Wang J
BMC Gastroenterol; 2024 May; 24(1):156. PubMed ID: 38720257
[TBL] [Abstract] [Full Text] [Related]
2. Individualized radiology screening for newly diagnosed nasopharyngeal carcinoma.
Xu Y; Xu T; Yao Q; Chen J; Hong H; Ding J; Qiu X; Chen C; Fei Z
Oral Oncol; 2024 Jun; 153():106828. PubMed ID: 38714114
[TBL] [Abstract] [Full Text] [Related]
3. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study.
Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ
Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of Induction Chemotherapy Followed by Chemoradiotherapy Versus Chemoradiotherapy Alone in Esophageal Squamous Cell Carcinoma Induction chemotherapy in Esophageal Squamous Cell Carcinoma.
Hosseini Toudeshki S; Garousi M; Arefpour AM; Fadavi P; Basi A; Foroughi A; Javadinia SA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1183-1188. PubMed ID: 38679976
[TBL] [Abstract] [Full Text] [Related]
5. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Kroese TE; Bronzwaer S; van Rossum PSN; Schoppman SF; Deseyne PRAJ; van Cutsem E; Haustermans K; Nafteux P; Thomas M; Obermannova R; Mortensen HR; Nordsmark M; Pfeiffer P; Elme A; Adenis A; Piessen G; Bruns CJ; Lordick F; Gockel I; Moehler M; Gani C; Liakakos T; Reynolds JV; Morganti AG; Rosati R; Castoro C; Cellini F; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; van Berge Henegouwen MI; Hulshoff MCCM; van Dieren J; Vollebergh M; van Sandick JW; Jeene P; Muijs C; Slingerland M; Voncken FEM; Hartgrink H; Creemers GJ; van der Sangen MJC; Nieuwenhuijzen GAP; Berbee M; Verheij M; Wijnhoven B; Beerepoot LV; Mohammad NH; Mook S; Ruurda JP; Kolodziejczyk P; Polkowski WP; Wyrwicz L; Alsina M; Tabernero J; Pera M; Kanonnikoff TF; Cervantes A; Nilsson M; Monig S; Wagner AD; Guckenberger M; Griffiths EA; Smyth E; Hanna GB; Markar S; Chaudry MA; Hawkins MA; Cheong E; van Laarhoven HWM; van Hillegersberg R;
Eur J Cancer; 2024 Jun; 204():114062. PubMed ID: 38678762
[TBL] [Abstract] [Full Text] [Related]
6. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
7. Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
Chen Y; Huang Y; Chen X; Chen Z; Peng X; Lin S; Lin C; Zong J
BMC Cancer; 2024 Apr; 24(1):483. PubMed ID: 38627711
[TBL] [Abstract] [Full Text] [Related]
8. Latin American Consensus on the Treatment of head and neck cancer.
Matos LL; Kowalski LP; Chaves ALF; de Oliveira TB; Marta GN; Curado MP; de Castro Junior G; Farias TP; Bardales GS; Cabrera MA; Capuzzo RC; de Carvalho GB; Cernea CR; Dedivitis RA; Dias FL; Estefan AM; Falco AH; Ferraris GA; Gonzalez-Motta A; Gouveia AG; Jacinto AA; Kulcsar MAV; Leite AK; Lira RB; Mak MP; De Marchi P; de Mello ES; de Matos FCM; Montero PH; de Moraes ED; de Moraes FY; Morais DCR; Poenitz FM; Poitevin A; Riveros HO; Sanabria Á; Ticona-Castro M; Vartanian JG; Viani G; Vines EF; William Junior WN; Conway D; Virani S; Brennan P;
JCO Glob Oncol; 2024 Apr; 10():e2300343. PubMed ID: 38603656
[TBL] [Abstract] [Full Text] [Related]
9. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract] [Full Text] [Related]
11. Impact of sarcopenia on overall survival and local relapse in head and neck cancer patients undergoing surgical excision.
Duymaz YK; Topcuoglu ED; Sahin S; Kucuk F; Erkmen B
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2161-2167. PubMed ID: 38567578
[TBL] [Abstract] [Full Text] [Related]
12. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
[TBL] [Abstract] [Full Text] [Related]
13. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
[TBL] [Abstract] [Full Text] [Related]
14. Performance of cone-beam computed tomography (CBCT) in comparison to conventional computed tomography (CT) and magnetic resonance imaging (MRI) for the detection of bone invasion in oral squamous cell cancer (OSCC): a prospective study.
Straub A; Linz C; Lapa C; Hartmann S; Kübler AC; Müller-Richter UDA; Faber J; Bley T; Brumberg J; Kertels O; Brands RC
BMC Oral Health; 2024 Mar; 24(1):341. PubMed ID: 38493083
[TBL] [Abstract] [Full Text] [Related]
15. 3D-IncNet: head and neck (H&N) Primary Tumors Segmentation and Survival Prediction.
Qayyum A; Benzinou A; Razzak I; Mazher M; Nguyen TT; Puig D; Vafaee F
IEEE J Biomed Health Inform; 2024 Mar; 28(3):1185-1194. PubMed ID: 38446658
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
[TBL] [Abstract] [Full Text] [Related]
17. Risk stratification of LA-NPC during chemoradiotherapy based on clinical classification and TVRR.
Tang Q; Mei C; Huang B; Huang R; Kang L; Chen A; Lei N; Deng P; Ying S; Zhang P; Qin Y
Cancer Med; 2024 Feb; 13(3):e7029. PubMed ID: 38396378
[TBL] [Abstract] [Full Text] [Related]
18. [Repairing partial suprahyoid epiglottis-preserved circumferential defect in near total laryngectomy with anterior medial thigh flap in advanced laryngeal cancer].
Yang L; Li W; Zheng Y; Ji L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 Feb; 38(2):133-139. PubMed ID: 38385223
[TBL] [Abstract] [Full Text] [Related]
19. First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study.
Soll D; Bischoff P; Frisch A; Jensen M; Karadeniz Z; Mogl MT; Horst D; Penzkofer T; Spranger J; Keilholz U; Mai K
BMC Endocr Disord; 2024 Feb; 24(1):25. PubMed ID: 38383419
[TBL] [Abstract] [Full Text] [Related]
20. Influence of Social Vulnerability in Treatment and Prognosis of Squamous Cell Carcinoma of the Tongue.
Fei-Zhang DJ; Park AC; Chelius DC; Smith SS; Samant S; Patel UA; Sheyn AM; Rastatter JC
Otolaryngol Head Neck Surg; 2024 May; 170(5):1338-1348. PubMed ID: 38353303
[TBL] [Abstract] [Full Text] [Related]
[Next]